Balancing Efficiency and Equity in Population-Wide CKD Screening
In this cost-effectiveness analysis, population-wide screening for CKD from ages 55 to 75 years was projected to improve population health, was cost-effective, and reduced disparities across 4 racial and ethnic groups. Starting population-wide screening at younger ages was projected to further benefit non-Hispanic Black adults.
Authors
- Douglas K. Owens
- Alyce S. Adams (ORCID: https://orcid.org/0000-0002-0146-4996)
- Jeremy D. Goldhaber‐Fiebert (ORCID: https://orcid.org/0000-0002-4007-5192)
- Glenn M. Chertow (ORCID: https://orcid.org/0000-0002-7599-0534)
- Joshua A. Salomon (ORCID: https://orcid.org/0000-0003-3929-5515)
- Marika Cusick (ORCID: https://orcid.org/0000-0002-1750-5246)
- Rebecca L. Tisdale (ORCID: https://orcid.org/0000-0003-2749-6889)
Institutions
- VA Palo Alto Health Care System (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.4740
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47